Ching-Hon Pui. Show Affiliations »
Abstract
Mesh: See more » Antineoplastic Agents/administration & dosageBrain Neoplasms/pathologyBrain Neoplasms/prevention & controlBrain Neoplasms/radiotherapyClinical ProtocolsDisease-Free SurvivalHumansPrecursor Cell Lymphoblastic Leukemia-Lymphoma/pathologyPrecursor Cell Lymphoblastic Leukemia-Lymphoma/prevention & controlPrecursor Cell Lymphoblastic Leukemia-Lymphoma/radiotherapy
Substances: See more » Antineoplastic Agents
Year: 2009 PMID: 19747877 DOI: 10.1016/S1470-2045(09)70239-6
Source DB: PubMed Journal: Lancet Oncol ISSN: 1470-2045 Impact factor: 41.316